NR565 | NR565 Advanced Pharmacology
Fundamentals Exam 1 v1 | Questions with Correct
Answers and Expert Explanation for Each Question
| Chamberlain
1. Which pharmacokinetic process is most significantly affected by the first-pass effect
when a drug is administered orally?
A. Metabolism
B. Excretion
C. Distribution
D. Absorption
Correct Answer: A
Expert Explanation: The first-pass effect refers to the rapid hepatic metabolism of
a drug before it reaches the systemic circulation. When drugs are absorbed from the
gastrointestinal tract, they enter the portal vein and go directly to the liver. This
process can significantly reduce the bioavailability of certain medications, requiring
higher oral doses compared to intravenous doses.
2. A drug with a high volume of distribution (Vd) is likely to have which of the
following characteristics?
A. Extensive tissue binding
,B. High plasma concentration
C. Low lipid solubility
D. Rapid renal excretion
Correct Answer: A
Expert Explanation: A high volume of distribution indicates that the drug has left
the plasma and is distributed extensively into the tissues. Drugs that are highly
lipid-soluble or exhibit significant tissue binding tend to have a larger Vd. This
parameter helps clinicians determine the loading dose required to achieve a target
plasma concentration.
3. According to the Controlled Substances Act, which schedule of drugs has a high
potential for abuse, no currently accepted medical use in the United States, and a lack
of accepted safety for use under medical supervision?
A. Schedule I
B. Schedule II
C. Schedule III
D. Schedule IV
Correct Answer: A
,Expert Explanation: Schedule I substances are defined as having a high potential
for abuse and no recognized medical utility in treatment. Examples of these
substances include heroin and lysergic acid diethylamide (LSD). Unlike Schedules II
through V, these drugs cannot be legally prescribed for routine therapeutic
purposes.
4. An agonist is a medication that binds to a receptor and produces which effect?
A. Blocks the endogenous ligand
B. Permanently deactivates the receptor
C. Decreases the affinity of other drugs
D. Mimics the action of the endogenous ligand
Correct Answer: D
Expert Explanation: An agonist is a molecule that activates a receptor by
mimicking the body’s own regulatory molecules. It possesses both affinity for the
receptor and intrinsic activity to trigger a biological response. This is contrasted
with antagonists, which bind to receptors but do not activate them, thereby blocking
agonist action.
5. How many half-lives does it typically take for a drug to reach a steady-state plasma
concentration?
A. 4 to 5
, B. 2 to 3
C. 1 to 2
D. 7 to 10
Correct Answer: A
Expert Explanation: Steady state is achieved when the rate of drug administration
equals the rate of drug elimination. In clinical pharmacology, it is generally accepted
that it takes approximately four to five half-lives for a drug to reach this plateau.
This principle applies regardless of the dosage amount, provided the dosing interval
remains constant.
6. Which of the following describes a ‘prodrug’?
A. A drug that is excreted unchanged by the kidneys
B. An inactive compound that is converted to an active drug through metabolism
C. A drug that is active upon administration but becomes toxic after metabolism
D. A drug that bypasses the liver entirely via sublingual administration
Correct Answer: B
Expert Explanation: A prodrug is a pharmacologically inactive substance that is
converted into an active metabolite through metabolic processes, usually in the
liver. This design is often used to improve the drug’s absorption, distribution, or
Fundamentals Exam 1 v1 | Questions with Correct
Answers and Expert Explanation for Each Question
| Chamberlain
1. Which pharmacokinetic process is most significantly affected by the first-pass effect
when a drug is administered orally?
A. Metabolism
B. Excretion
C. Distribution
D. Absorption
Correct Answer: A
Expert Explanation: The first-pass effect refers to the rapid hepatic metabolism of
a drug before it reaches the systemic circulation. When drugs are absorbed from the
gastrointestinal tract, they enter the portal vein and go directly to the liver. This
process can significantly reduce the bioavailability of certain medications, requiring
higher oral doses compared to intravenous doses.
2. A drug with a high volume of distribution (Vd) is likely to have which of the
following characteristics?
A. Extensive tissue binding
,B. High plasma concentration
C. Low lipid solubility
D. Rapid renal excretion
Correct Answer: A
Expert Explanation: A high volume of distribution indicates that the drug has left
the plasma and is distributed extensively into the tissues. Drugs that are highly
lipid-soluble or exhibit significant tissue binding tend to have a larger Vd. This
parameter helps clinicians determine the loading dose required to achieve a target
plasma concentration.
3. According to the Controlled Substances Act, which schedule of drugs has a high
potential for abuse, no currently accepted medical use in the United States, and a lack
of accepted safety for use under medical supervision?
A. Schedule I
B. Schedule II
C. Schedule III
D. Schedule IV
Correct Answer: A
,Expert Explanation: Schedule I substances are defined as having a high potential
for abuse and no recognized medical utility in treatment. Examples of these
substances include heroin and lysergic acid diethylamide (LSD). Unlike Schedules II
through V, these drugs cannot be legally prescribed for routine therapeutic
purposes.
4. An agonist is a medication that binds to a receptor and produces which effect?
A. Blocks the endogenous ligand
B. Permanently deactivates the receptor
C. Decreases the affinity of other drugs
D. Mimics the action of the endogenous ligand
Correct Answer: D
Expert Explanation: An agonist is a molecule that activates a receptor by
mimicking the body’s own regulatory molecules. It possesses both affinity for the
receptor and intrinsic activity to trigger a biological response. This is contrasted
with antagonists, which bind to receptors but do not activate them, thereby blocking
agonist action.
5. How many half-lives does it typically take for a drug to reach a steady-state plasma
concentration?
A. 4 to 5
, B. 2 to 3
C. 1 to 2
D. 7 to 10
Correct Answer: A
Expert Explanation: Steady state is achieved when the rate of drug administration
equals the rate of drug elimination. In clinical pharmacology, it is generally accepted
that it takes approximately four to five half-lives for a drug to reach this plateau.
This principle applies regardless of the dosage amount, provided the dosing interval
remains constant.
6. Which of the following describes a ‘prodrug’?
A. A drug that is excreted unchanged by the kidneys
B. An inactive compound that is converted to an active drug through metabolism
C. A drug that is active upon administration but becomes toxic after metabolism
D. A drug that bypasses the liver entirely via sublingual administration
Correct Answer: B
Expert Explanation: A prodrug is a pharmacologically inactive substance that is
converted into an active metabolite through metabolic processes, usually in the
liver. This design is often used to improve the drug’s absorption, distribution, or
